How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors' associated rash?
Cholongitas
Evangelos
E
Kokolakis
George
G
Ioannidou
Despina
D
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000382:microbiology* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D016868:Serratia Infections / Q000150:complications; D012706:Serratia marcescens; D013492:Suppuration / Q000382:microbiology
D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors